This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.
The goal of pharmacologic therapy for sleep apnea syndrome is to restore airway competence, to reduce morbidity and excessive mortality by reversing underlying hypoxia, hypercapnia, and acidosis, and to improve the quality of life for the patient.